1-6 of 6
Lingling Shi
Close
Sort by
Journal Articles

Safety and Efficacy of RM-001 (Autologous HBG1/2 Promoter-modified CD34+ Hematopoietic Stem and Progenitor Cells) in Patients with Transfusion-Dependent β-Thalassemia

Rongrong Liu, Li Wang, Hui Xu, Xiaolin Yin, Junbin Liang, Wenqiang Xie, Gaohui Yang, Yaoyun Li, Yali Zhou, Lei Shi, Bin Xiao, Lingling Shi, Zeyan Shi, Xuemei Zhou, Xiangmin Xu, Jianpei Fang, Yongrong Lai, Junjiu Huang, Xinhua Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4994.
https://doi.org/10.1182/blood-2023-181453
Published: 2023
Journal Articles

Addition of Daclizumab to Standard Graft-Versus-Host Disease Prophylaxis in Patients with Thalassemia Major Undergoing Transplantation from Related Haploidentical Donor and Unrelated Donor Hematopoietic Stem-Cell Transplantation: A Single-Center Retrospective Analysis from China

Rongrong Liu, Gaohui Yang, Lingling Shi, Lianjin Liu, Zhongming Zhang, Cuifeng Huang, Zhenbin Wei, Beicai Liu, Zhaoping Gan, Wenqiang Xie, Rui Huang, Na Sun, Shuyi Wei, Xuemei Zhou, Yinghua Chen, Yanye Liu, Zhi Li, Qifa Liu, Yongrong Lai
Journal: Blood
Blood (2023) 142 (Supplement 1): 5252.
https://doi.org/10.1182/blood-2023-180056
Published: 2023
Journal Articles

Letermovir Prophylaxis for Cytomegalovirus Reactivation in β Thalassemia Major Children after Hematopoietic Cell Transplantation

Lingling Shi, Rongrong Liu, Zhongming Zhang, Cuifeng Huang, Lianjin Liu, Yibin Yao, Zhenbin Wei, Shuyi Wei, Zhaoping Gan, Na Sun, Beicai Liu, Rui Huang, Xuemei Zhou, Yinghua Chen, Qifa Liu, Yongrong Lai
Journal: Blood
Blood (2023) 142 (Supplement 1): 7053.
https://doi.org/10.1182/blood-2023-189043
Published: 2023
Journal Articles

Basiliximab in the Prevention of aGVHD for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Major: A Prospective, Multicenter, Open-Label, Randomized Controlled Study

Rongrong Liu, Meiqing Wu, Qiaochuan Li, Lianjin Liu, Chunjie Qin, Hong Chen, Lingling Shi, Gaohui Yang, Zeyan Shi, Zhongqing Li, Zhenbin Wei, Beicai Liu, Jing Fan, Yinghua Chen, Xuemei Zhou, Zhongming Zhang, Yongrong Lai, Qifa Liu
Journal: Blood
Blood (2022) 140 (Supplement 1): 1383–1384.
https://doi.org/10.1182/blood-2022-166003
Published: 2022
Journal Articles

Preliminary Result of the Safety and Efficacy of Autologous HBG1/2 Promoter-Modified CD34+ Hematopoietic Stem and Progenitor Cells (RM-001) in Transfusion-Dependent Βeta-Thalassemia

Rongrong Liu, Hui Xu, Junbin Liang, Wenqiang Xie, Gaohui Yang, Lei Shi, Lingling Shi, Jianpei Fang, Chunfu Li, Zeyan Shi, Xuemei Zhou, Junjiu Huang, Yongrong Lai
Journal: Blood
Blood (2022) 140 (Supplement 1): 4915–4916.
https://doi.org/10.1182/blood-2022-169151
Published: 2022
Journal Articles

Idarubicin Intensified Bucy Regimen in Allogeneic Peripheral Blood Stem Cell Transplantation for High-Risk Acute Myeloid Leukemia: A Multicenter, Randomized Study (NCT 01766375)

Qiaochuan Li, Meiqing Wu, Zhongming Zhang, Lianjin Liu, Lingling Shi, Qifa Liu, Yongrong Lai
Journal: Blood
Blood (2017) 130 (Supplement 1): 597.
https://doi.org/10.1182/blood.V130.Suppl_1.597.597
Published: 2017